Livsmed Inc (KOSDAQ:491000)

Market Cap	1.53T
Revenue (ttm)	51.19B +88.8%
Net Income	-22.87B
EPS	-1,030.07
Shares Out	24.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	308,221
Average Volume	353,287
Open	66,500
Previous Close	66,600
Day's Range	61,200 - 66,900
52-Week Range	46,250 - 95,900
Beta	n/a
RSI	41.69
Earnings Date	Apr 14, 2026

About Livsmed

Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2011
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 491000

Financial Performance

In 2025, Livsmed's revenue was 51.19 billion, an increase of 88.75% compared to the previous year's 27.12 billion. Losses were -22.87 billion, -10.60% less than in 2024.